These Analysts Slash Their Forecasts On Western Union Following Weaker-Than-Expected Q2 Earnings

Western Union (WU) reported downbeat second-quarter results, with earnings of 42 cents per share and sales of $1.026 billion both missing analyst consensus estimates. The disappointing performance led to a 3.2% decline in WU shares and prompted multiple analysts, including Susquehanna, Keefe, Bruyette & Woods, UBS, RBC Capital, Morgan Stanley, and JP Morgan, to maintain their ratings but significantly lower their price targets, signaling a cautious outlook for the company despite management's commentary on business resilience amidst macroeconomic uncertainty.

Analysis

Western Union (WU) reported a downbeat second quarter, missing analyst consensus estimates on both revenue and earnings. The company posted quarterly sales of $1.026 billion against a $1.040 billion estimate and earnings of 42 cents per share, two cents below the consensus of 44 cents. This underperformance led to a direct negative market reaction, with shares falling 3.2% to $8.17. While management cited the execution of its 'Evolve 2025' strategy and the business's resilience in a difficult macroeconomic environment, this commentary was met with significant skepticism from Wall Street. In a strong bearish signal, at least six analyst firms, including Morgan Stanley and JP Morgan, responded by lowering their price targets. The new targets range from as low as $7.00 to $10.00, a substantial reduction from previous levels (e.g., RBC Capital's cut from $13 to $9). The uniformity of these downward revisions, even from analysts maintaining Neutral or Market Perform ratings, indicates a broad-based deterioration in the company's perceived near-term outlook.

Key Decisions for Investors

• Given the dual miss on revenue and earnings, coupled with the wave of uniformly negative price target revisions from analysts, investors should exercise caution as the market consensus points to significant operational and macroeconomic headwinds.
• Investors holding long positions may want to re-evaluate their investment thesis, as the new analyst price targets, now ranging from $7 to $10, suggest a significantly lower valuation ceiling in the near term.
• Before considering a new position, it is critical to monitor for tangible signs of progress from the 'Evolve 2025' strategy in future quarters, as the current results suggest it is not yet offsetting the prevailing economic uncertainty.